Activation of the hypoxia pathway in breast cancer tissue and patient survival are inversely associated with tumor ascorbate levels

EJ Campbell, GU Dachs, HR Morrin, VC Davey… - BMC cancer, 2019 - Springer
Background The transcription factor hypoxia inducible factor (HIF)-1 drives tumor growth and
metastasis and is associated with poor prognosis in breast cancer. Ascorbate can moderate …

Signaling pathways in the regulation of cancer stem cells and associated targeted therapy

W Manni, W Min - MedComm, 2022 - Wiley Online Library
Cancer stem cells (CSCs) are defined as a subpopulation of malignant tumor cells with
selective capacities for tumor initiation, self‐renewal, metastasis, and unlimited growth into …

Functional interplay between long non-coding RNAs and Breast CSCs

BM Hussen, RK Kheder, ST Abdullah, HJ Hidayat… - Cancer Cell …, 2022 - Springer
Breast cancer (BC) represents aggressive cancer affecting most women's lives globally.
Metastasis and recurrence are the two most common factors in a breast cancer patient's …

[HTML][HTML] Cancer stem cells, epithelial-mesenchymal transition, ATP and their roles in drug resistance in cancer

H Zhang, A Steed, M Co, X Chen - Cancer Drug Resistance, 2021 - ncbi.nlm.nih.gov
The cancer stem cell (CSC) state and epithelial-mesenchymal transition (EMT) activation are
tightly interconnected. Cancer cells that acquire the EMT/CSC phenotype are equipped with …

Regulatory role of quiescence in the biological function of cancer stem cells

SH Lee, T Reed-Newman, S Anant… - Stem Cell Reviews and …, 2020 - Springer
Quiescence in cancer cells is considered a therapeutic challenge as it confers dormancy in
tumour, hence circumventing inherent anti-neoplastic surveillance system and standard-of …

[HTML][HTML] Magnesium alloys in tumor treatment: Current research status, challenges and future prospects

Y Hsu, Y Lu, S Wang, Y Zheng, D Xia, Y Liu - Journal of Magnesium and …, 2023 - Elsevier
Cancer is a major threat to human life worldwide. Traditional cancer treatments, such as
chemotherapy and surgery, have major limitations and can cause irreversible damage to …

Dual or multiple drug loaded nanoparticles to target breast cancer stem cells

Y Gao, M Tang, E Leung, D Svirskis, A Shelling, Z Wu - RSC advances, 2020 - pubs.rsc.org
Breast cancer stem (-like) cells (BCSCs) have been found to be responsible for therapeutic
resistance and disease relapse. BCSCs are difficult to eradicate due to their high resistance …

[HTML][HTML] HIF1α/HIF2α induces glioma cell dedifferentiation into cancer stem cells through Sox2 under hypoxic conditions

P Wang, S Gong, B Liao, J Pan, J Wang, D Zou… - Journal of …, 2022 - ncbi.nlm.nih.gov
Objective: Our previous study showed that glioma stem-like cells could be induced to
undergo dedifferentiation under hypoxic conditions, but the mechanism requires further …

Cellular signaling in the hypoxic cancer microenvironment: Implications for drug resistance and therapeutic targeting

HA Bakshi, M Mkhael, HL Faruck, AU Khan… - Cellular …, 2023 - Elsevier
The rewiring of cellular metabolism is a defining characteristic of cancer, as tumor cells
adapt to acquire essential nutrients from a nutrient-poor environment to sustain their viability …

Role of cancer‑associated fibroblasts in the resistance to antitumor therapy, and their potential therapeutic mechanisms in non‑small cell lung cancer

C Chen, J Hou, S Yu, W Li, X Wang… - Oncology …, 2021 - spandidos-publications.com
Non‑small cell lung cancer (NSCLC) is a malignant tumor with high morbidity and mortality
rates, which seriously endangers human health. Although treatment methods continue to …